Inhaled corticosteroids for stable chronic obstructive pulmonary disease

2012522 citationsReviewgreen Open Access

Authors

Melissa Clarke · Royal Brisbane and Women's Hospital

Esther Sim · Royal Brisbane and Women's Hospital

Abstract

Patients and clinicians should balance the potential benefits of inhaled steroids in COPD (reduced rate of exacerbations, reduced rate of decline in quality of life and possibly reduced rate of decline in FEV(1)) against the potential side effects (oropharyngeal candidiasis and hoarseness, and risk of pneumonia).

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Neonatal Respiratory Health Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cochrane Database of Systematic Reviews

Volume 2016, Issue 8, pp. CD002991-CD002991

DOI: 10.1002/14651858.cd002991.pub3

Field-Weighted Citation Impact: 33.60